InvestSMART

Neuren Pharmaceuticals Limited (ASX: NEU) - Announcements

Current share price for NEU : $20.785 0.105 (0.51%)+

ASX company news and announcements for Neuren Pharmaceuticals Limited (NEU) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Neuren Pharmaceuticals Limited (NEU) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Neuren Pharmaceuticals Limited (NEU), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Neuren Pharmaceuticals Limited (NEU)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$2,633 Update - Dividend/Distribution - NEU 18 Sep 2026 4:12PM $20.680 $20.770 risen by 0.44%
$2,633 Corporate Presentation, 2 September 2026 2 Sep 2026 8:50AM $19.890 $20.770 risen by 4.42%
$2,633 Dividend/Distribution - NEU 26 Aug 2026 4:56PM $20.150 $20.770 risen by 3.08%
$2,633 Investor presentation, 26 August 2026 26 Aug 2026 10:40AM $22.370 $20.770 fallen by 7.15%
$2,633 Growing royalty anchors Neuren first ever dividend program 26 Aug 2026 9:47AM $22.530 $20.770 fallen by 7.81%
$2,633 Half Yearly Report and Accounts 26 Aug 2026 9:25AM $22.530 $20.770 fallen by 7.81%
$2,633 European Commission grants marketing authorisation for DAYBU 25 Aug 2026 8:31AM $22.450 $20.770 fallen by 7.48%
$2,633 Neuren H1 2026 Financial Results Webinar on 26 August 2026 21 Aug 2026 3:19PM $22.420 $20.770 fallen by 7.36%
$2,633 Record Q2 DAYBUE net sales of US$125m, CY26 royalty upgraded 5 Aug 2026 9:52AM $18.610 $20.770 risen by 11.61%
$2,633 Neuren highlights participation in PMSF Family Conference 24 Jul 2026 9:57AM $16.460 $20.770 risen by 26.18%
$2,633 DAYBU recommended for approval in the European Union 29 Jun 2026 7:43AM $12.200 $20.770 risen by 70.25%
$2,633 Application for quotation of securities - NEU 18 Jun 2026 4:49PM $13.250 $20.770 risen by 56.75%
$2,633 Notification of cessation of securities - NEU 1 Jun 2026 5:47PM $14.210 $20.770 risen by 46.16%
$2,633 Notification regarding unquoted securities - NEU 1 Jun 2026 5:40PM $14.210 $20.770 risen by 46.16%
$2,633 Results of Meeting 27 May 2026 4:00PM $13.810 $20.770 risen by 50.40%
$2,633 AGM Chair Address & CEO Presentation 27 May 2026 1:22PM $14.410 $20.770 risen by 44.14%
$2,633 Update - Notification of buy-back - NEU 14 May 2026 7:30AM $12.710 $20.770 risen by 63.41%
$2,633 Launch of Investor Hub to enhance shareholder engagement 12 May 2026 3:56PM $12.870 $20.770 risen by 61.38%
$2,633 Notification of cessation of securities - NEU 12 May 2026 8:34AM $13.390 $20.770 risen by 55.12%
$2,633 Update - Notification of buy-back - NEU 12 May 2026 8:32AM $13.390 $20.770 risen by 55.12%
$2,633 Update - Notification of buy-back - NEU 11 May 2026 8:45AM $12.800 $20.770 risen by 62.27%
$2,633 Q1 2026 DAYBUE net sales US$101m, up 20% from Q1 2025 7 May 2026 9:53AM $12.320 $20.770 risen by 68.59%
$2,633 Update - Notification of buy-back - NEU 6 May 2026 10:31AM $12.510 $20.770 risen by 66.03%
$2,633 Update - Notification of buy-back - NEU 29 Apr 2026 8:45AM $11.930 $20.770 risen by 74.10%
$2,633 Virtual AGM online guide 24 Apr 2026 1:27PM $12.225 $20.770 risen by 69.90%

1 - 25 of 831 results

Page 1 of 34

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.